PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 21, 2026Frontiers in Oncology0 citationsOpen Access

Correction: Improving the therapeutic efficacy of sorafenib for hepatocellular carcinoma by repurposing disulfiram

GZGong ZhangYWYue WangBFBryan C. Fuchs

Key Points

  • This paper aims to improve the effectiveness of the cancer drug sorafenib by using disulfiram in treating hepatocellular carcinoma.
  • Review of the therapeutic use of disulfiram alongside sorafenib.
  • Analysis of treatment outcomes in hepatocellular carcinoma models.
  • Identification of enhanced efficacy of sorafenib when combined with disulfiram.
  • Correction of figure detailing the wrong visual representation.

Abstract

H, Cai L, Zhang L, Tanabe KK and Wang X (2022) Improving the Therapeutic Efficacy of Sorafenib for Hepatocellular Carcinoma by Repurposing Disulfiram. Front. Oncol. 12:913736. doi: 10.3389/fonc.2022.913736In the published article, there was an error in Figure 2E as published. Some of the sphere images were unintentionally duplicated during the preparation process. The corrected Figure 2E and its caption appear below.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Zhang et al. (2026) studied this question.

synapsesocial.com/papers/69994bdd873532290d01feb3https://doi.org/10.3389/fonc.2026.1772315
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Abstract 4547: A novel drug combination with improved therapeutic efficacy over sorafenib in multiple preclinical models of hepatocellular carcinoma2024 · 1 citations
  2. 2Improving Sorafenib Efficacy in HCC Tumour Cores via PDE5 Inhibitor‐Mediated Vasodilation in Hypoxic Microenvironments: Targeting the Glycolytic Pathway2025 · 1 citations
  3. 3Preparation and characterization of Sorafenib nano-emulsion: impact on pharmacokinetics and toxicity; an in vitro and in vivo study2024 · 30 citations
  4. 4Enhanced Apoptosis in Hepatocellular Carcinoma via Nanoscale Liposomal Codelivery of Ginsenoside CK and Sorafenib2026
  5. 5Review article: Pharmacological therapy for hepatocellular carcinoma with sorafenib and other oral agents.2008